Kura Oncology, Inc. License Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifth Amendment to Patent License Agreement between Kura Oncology, Inc. and the Regents of the University of Michigan
License Agreements
Kura Oncology, Inc.
Biotechnology
2021
Patent License Agreement between Kura Oncology, Inc. and the Regents of the University of Michigan
License Agreements
Kura Oncology, Inc.
Biotechnology
MI
2021
License Agreement Between Kura Oncology, Inc. and Janssen Pharmaceutica NV for Tipifarnib Rights
License Agreements
Kura Oncology, Inc.
Biotechnology
NY
2021
Amendment 6 to Patent License Agreement between Kura Oncology, Inc. and The Regents of the University of Michigan
License Agreements
Kura Oncology, Inc.
Biotechnology
2018
Fifth Amendment to Patent License Agreement between Kura Oncology, Inc. and the Regents of the University of Michigan
License Agreements
Kura Oncology, Inc.
Biotechnology
2017
Patent License Agreement between Kura Oncology, Inc. and the Regents of the University of Michigan
License Agreements
Kura Oncology, Inc.
Biotechnology
MI
2017
Amendment No. 1 to License Agreement between Kura Oncology, Inc. and Janssen Pharmaceutica NV
License Agreements
Kura Oncology, Inc.
Biotechnology
2016
License Agreement between Kura Oncology, Inc. and Janssen Pharmaceutica NV for Tipifarnib Rights
License Agreements
Kura Oncology, Inc.
Biotechnology
NY
2015
License Agreement between Kura Oncology, Inc. and Janssen Pharmaceutica NV for Tipifarnib Rights
License Agreements
Kura Oncology, Inc.
Biotechnology
NY
2015